Cited by 40Organ Transplantation Techniques and OutcomesLiver Disease and TransplantationTransplantation: Methods and Outcomes

New Developments and Challenges in Liver Transplantation

Open access
Khalil, Amjad, Quaglia, Alberto, Gélat, Pierre, Saffari, Nader, Rashidi, Hassan, Davidson, Brian·2023·Journal of Clinical Medicine

Abstract

Liver disease is increasing in incidence and is the third most common cause of premature death in the United Kingdom and fourth in the United States. Liver disease accounts for 2 million deaths globally each year. Three-quarters of patients with liver disease are diagnosed at a late stage, with liver transplantation as the only definitive treatment. Thomas E. Starzl performed the first human liver transplant 60 years ago. It has since become an established treatment for end-stage liver disease, both acute and chronic, including metabolic diseases and primary and, at present piloting, secondary liver cancer. Advances in surgical and anaesthetic techniques, refined indications and contra-indications to transplantation, improved donor selection, immunosuppression and prognostic scoring have allowed the outcomes of liver transplantation to improve year on year. However, there are many limitations to liver transplantation. This review describes the milestones that have occurred in the development of liver transplantation, the current limitations and the ongoing research aimed at overcoming these challenges.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm12175586

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liver transplantation is limited by global donor shortages, excessive costs, and long-term adverse effects of immunosuppressive drugs.

    “Its application is, however, limited by persistent constraints, including global donor shortages leading to waitlist times and death, excessive costs (surgery, long-term immunosuppression, and follow-up), and long-term adverse effects of infections, metabolic complications, and malignancies associated with immunosuppressive drugs [10, 11].”

    From From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy (2025) · cites this paper as [11]

    Sections 3.2 and 3.4 describe worldwide donor shortages, waiting-list deaths, and high transplantation costs; sections 2.2 and 4.6 describe risks from immunosuppression and its lifelong use. The paper does not specify the cited cost breakdown or clearly attribute metabolic complications to immunosuppressive drugs. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Liver transplantation remains the only curative option for end-stage liver disease.

    “Liver transplantation remains the only curative option for end-stage liver disease, and refinements in surgical procedures, immunosuppressive therapy, and postoperative management have significantly enhanced patient survival and quality of life.”
  • Advanced stages of cirrhosis often require liver transplantation, which is undermined by donor shortage and logistical setbacks.

    “Although early interventions can retard or reverse early injury, advanced stages often call for liver transplantation—a therapy undermined by donor shortage and logistical setbacks.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 85 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [76]Shah N.J. Mousa O.Y. Syed K. John S. Acute On Chronic Liver Failure StatPearls StatPearls Publishing Treasure Island, FL, USA 2023 Available online: https://www.ncbi.nlm.nih.gov/books/NBK499902/ (accessed on 2 January 2023) 29763077

Cited by

Sorted by citations

Authors
Khalil, A., Quaglia, A., Gélat, P., Saffari, N., Rashidi, H., & Davidson, B.
Affiliations
  • The Royal Free Hospital (GB)
  • University College London (GB)
Corresponding author
  • Khalil, Amjad
  • Davidson, Brian
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2023-08-27
Volume
12
Issue
17
Pages
5586
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4386224189
Cited by
40
References
85
Citations by year
2026: 10 · 2025: 18 · 2024: 12
FWCI
2.59
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion, cc-by)
Funders
Wellington Hospital, HCA London And Rosetrees Trust (2020\100261)
Topics
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
liver transplantation, end-stage liver disease, history of liver transplantation, donor selection, immunosuppression, prognostic scoring, transplant indications and contraindications, liver cancer, metabolic liver disease, transplant outcomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review